These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Augmentation of clozapine partial responders with conventional antipsychotics. Rajarethinam R; Gilani S; Tancer M; DeQuardo J Schizophr Res; 2003 Mar; 60(1):97-8. PubMed ID: 12505145 [No Abstract] [Full Text] [Related]
4. Correlated changes in symptoms and neurotransmitter indices during maintenance treatment with clozapine or conventional neuroleptics in adolescents and young adults with schizophrenia. Schulz E; Fleischhaker C; Remschmidt HE J Child Adolesc Psychopharmacol; 1996; 6(2):119-31. PubMed ID: 9231304 [TBL] [Abstract][Full Text] [Related]
5. Clinical and biologic response to clozapine in patients with schizophrenia. Crossover comparison with fluphenazine. Pickar D; Owen RR; Litman RE; Konicki E; Gutierrez R; Rapaport MH Arch Gen Psychiatry; 1992 May; 49(5):345-53. PubMed ID: 1375019 [TBL] [Abstract][Full Text] [Related]
6. Neurochemical variables in schizophrenic patients during switching from neuroleptics to clozapine. Hatzimanolis J; Lykouras L; Markianos M; Oulis P Prog Neuropsychopharmacol Biol Psychiatry; 1998 Oct; 22(7):1077-85. PubMed ID: 9829289 [TBL] [Abstract][Full Text] [Related]
7. Autonomic effects of clozapine in schizophrenia: comparison with placebo and fluphenazine. Zahn TP; Pickar D Biol Psychiatry; 1993 Jul 1-15; 34(1-2):3-12. PubMed ID: 8104043 [TBL] [Abstract][Full Text] [Related]
8. The brain metabolic patterns of clozapine- and fluphenazine-treated patients with schizophrenia during a continuous performance task. Cohen RM; Nordahl TE; Semple WE; Andreason P; Litman RE; Pickar D Arch Gen Psychiatry; 1997 May; 54(5):481-6. PubMed ID: 9152102 [TBL] [Abstract][Full Text] [Related]
10. The effects of typical and atypical neuroleptics on mitogen-induced T lymphocyte responsiveness. Rapaport MH; McAllister CG; Kirch DG; Pickar D Biol Psychiatry; 1991 Apr; 29(7):715-7. PubMed ID: 1711382 [No Abstract] [Full Text] [Related]
11. Clozapine as a first treatment for schizophrenia. Woerner MG; Robinson DG; Alvir JM; Sheitman BB; Lieberman JA; Kane JM Am J Psychiatry; 2003 Aug; 160(8):1514-6. PubMed ID: 12900316 [TBL] [Abstract][Full Text] [Related]
13. [Effect of clozapine on biogenic amines within the scope of drug treatment of schizophrenic psychoses in adolescence]. Schulz E; Remschmidt H; Fleischhaker C Z Kinder Jugendpsychiatr; 1994 Dec; 22(4):285-98. PubMed ID: 7856324 [TBL] [Abstract][Full Text] [Related]
14. Biogenic amines as predictors of response to clozapine treatment in early-onset schizophrenia. Fleischhaker C; Schulz E; Remschmidt H J Psychiatr Res; 1998; 32(5):325-33. PubMed ID: 9789212 [TBL] [Abstract][Full Text] [Related]
17. HLA-A2 and B35 are strong predictors of responsiveness to clozapine: preliminary data in Italian schizophrenia patients. Marchini M; Scorza R; Antonioli R; Scarone S; Grassi B; Epifani M; Dragoni C Schizophr Res; 2001 Mar; 48(2-3):363-5. PubMed ID: 11368031 [No Abstract] [Full Text] [Related]
19. Elevated clozapine serum level after treatment with amiodarone. Stevens JR; Freudenreich O; Stern TA Psychosomatics; 2008; 49(3):255-7. PubMed ID: 18448783 [No Abstract] [Full Text] [Related]
20. Commentary on "clinical studies on the mechanism of action of clozapine; the dopamine-serotonin hypothesis of schizophrenia." Psychopharmacology (1989) 99:S18-S27. Meltzer HY Psychopharmacology (Berl); 2002 Aug; 163(1):1-3. PubMed ID: 12185394 [No Abstract] [Full Text] [Related] [Next] [New Search]